Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43:55–68.
Tunbridge WMG, Vanderpump MPJ. Population screening for autoimmune thyroid disease. Endocrinol Metab Clin North Am. 2000;29:239–53.
Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol. 2003;148:1–9.
Collins J, Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med. 2002;29 Suppl 2:S417–24.
Fournier M, Brousseau P, Tryphonas H, Cyr D. Biomarkers of immunotoxicity: an evolutionary perspective. In: Guillette Jr LJ, Crain DA, editors. Environmental endocrine disrupters: an evolutionary perspective. New York: Taylor & Francis; 2000. p. 182–215.
Allsopp M, Costner P, Johnston P. Body of evidence: the effects of chlorine on human health. Pull: Greenpeace International, 1995. ISBN 1857/532 2590, 90pp.Accessd on 19 June 2009
Liu CC, Chen CC, Wu TN, Yang CY. Association of brain cancer with residential exposure to petrochemical air pollution in Taiwan. J Toxicol Environ Health. 2008;A71(5):310–4.
Yang CY, Chiu HF, Tsai SS, Chang CC, Chuang HY. Increased risk of preterm delivery in areas with cancer mortality problems from petrochemical complex. Environ Res. 2002;69(3):195–200.
Neuberger JS, Ward-Smith P, Morantz RA, Tian C, Schmelzie KH, Mayo MS, Chin TD. Brain cancer in a residential area bordering on an oil refinery. Neuroepidemiology. 2003;22(1):46–56.
Langer P, Kocan A, Tajtakova M, Petrik J, Chovancova J, Drobna B, Jursa S, Pavuk M, Trnovec T, Seböková E, Klimes I. Human thyroid in the population exposed to high environmental pollution by organochlorinated pollutants for several decades. Endocr Regul. 2005;39(1):13–20.
Rádiková Z, Tajtáková M, Kocan A, Trnovec T, Seböková E, Klimes I, Langer P. Possible effects of environmental nitrates and toxic organochlorines on human thyroid in highly polluted areas in Slovakia. Thyroid. 2008;18(3):353–62.
CETESB 2008. Available at: http://www.cetesb.sp.gov.br>. Accessed on 2 April 2010
Akamizu T, Amino N, De Groot LJ. Hashimoto’s thyroiditis. Thyroid Disease Manager 2008. Available at:http://www.thyroidmanager.org/Chapter8/8-contents.htm. Accessed on 6 March 2011
Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996;335(2):99–107.
Esteves RZ, Kasamatsu TS, Kunii IS, Furuzawa GK, Vieira JGH, Maciel RMB. Development of a semi-automated method of measuring urinary iodine and its application in epidemiological studies in Brazilian schoolchildren [Port]. Brazilian Arch Endocrinol Metab. 2007;51/9:1477–84.
Zaccarelli-Marino MA, Martins LC, Esteves RZ, Kasamatsu TS, Maciel RMB. Urinary iodine in patients with auto-immune Thyroid disorders in Santo André, SP, is comparable to normal controls and has been steady for the last 10 years [Port]. Brazilian Arch Endocrinol Metab. 2009;53/1:55–63.
Paknys G, Kondrotas AJ, Kevelaitis E. Risk factors and pathogenesis of Hashimoto’s thyroiditis. Medicina (Kaunas). 2009;45(7):574–83.
Rose NR, Rasooly L, Saboori AM, Burek CL. Linking iodine with autoimmune thyroiditis. Environ Health Perspect. 1999;107:749–52.
Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004;150:605–18.
Aminorroaya A, Janghorbani M, Amini M, Hovsepian S, Tabatabaei A, Fallah Z. The prevalence of thyroid dysfunction in an iodine-sufficient area in Iran. Arch Iranian Med. 2009;12(3):262–70.
Langer P, Tajtáková M, Fodor G, Kocan A, Bohov P, Michálek J, Kreze A. Increased thyroid volume and prevalence of thyroid disorders in an area heavily polluted by polychlorinated biphenyls. Eur J Endocrinol. 1998;139(4):402–9.
Delange F, Benker G, Caron Ph, Eber O, Ott W, Peter F, Podoba J, Simescu M, Szybinsky Z, Vertongen F, Vitti P, Wiersinga W, Zamrazil V. Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. Eur J Endocrinol. 1997;136:180–7.
Gilbert KM, Griffin JM, Pumford NR. Trichloroethylene activates CD4+ T cells: potential role in an autoimmune response. Drug Metab Rev. 1999;31(4):901–16.
Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology. 2000;46:123–37.
Gist GL, Burg JR. Trichloroethylene: a review of the literature from a health effects perspective. Toxicol Ind Health. 1995;11:253–307.
Agency for Toxic Substances and Disease Registry (ATSDR). National exposure registry, trichloroethylene subregistry baseline technical report (revised). 1994. US Department of Health and Human Services, Public Health Service, Atlanta, GA.
Selgrade MK. Immunotoxicity: the risk is real. Toxicol Sci. 2007;100(2):328–32.
Rizzo M, Rossi RT, Bonaffini O, Scisca C, Altavilla G, Calbo L, Rosano A, Sindoni A, Trimarchi F, Benvenga S. Increased annual frequency of Hashimoto’s thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann Endocrinol (Paris). 2010;71(6):525–34.
Benvenga S, Trimarchi F. Changed presentation of Hashimoto’s thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid. 2008;18(4):429–41.
Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid diseases. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text, 8/E. Philadelphia: JB Lippincott- Raven; 2000. p. 467–73.
PetrochemicalComplexABC2008.Availableat:attp://www.agenciabrasil.gov.br/noticias/2008/02/22.Accessed on 12 December 2009.
Landrigan PG. Children as a vulnerable population. Int J Occup Med Environ Health. 2004;17(1):175–7.
Freitas CU, Campos RAG, Silva MAFR, Panachão MRI, Moraes JC, Waissmann W, Chacra AR, Maeda MYS, Rodrigues RSM, Belchor LG, Barbosa SO, Santos RTM. Can living in the surroundings of a petrochemical complex be a risk factor for autoimmune thyroid disease? Environ Res. 2010;110:112–7.
Kilburn KH, Washaw RW. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well. Environ Res. 1992;57:1–9.
Lockey JE, Kelly CR, Cannon GW, Colby TV, Aldrich V, Livingston GK, Lockey JE, Kelly CR, Cannon GW, Colby TV, Aldrich V, Livingston GK. Progressive systemic sclerosis associated with exposure to trichloroethylene. J Occup Med. 1997;29:493–6.
Martin A, Barbesino G, Davies TF. T-cell receptors and autoimmune thyroid disease-signposts for T-cell-antigen driven diseases. Int Rev Immunol. 1999;18:111–40.